| 000 | 01575 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518013017.0 | ||
| 264 | 0 | _c20191114 | |
| 008 | 201911s 0 0 eng d | ||
| 022 | _a2284-0729 | ||
| 024 | 7 |
_a10.26355/eurrev_201811_16421 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMiao, C-Q | |
| 245 | 0 | 0 |
_aIncreased serum nardilysin is associated with worse long-term outcome of ST-elevation myocardial infarction. _h[electronic resource] |
| 260 |
_bEuropean review for medical and pharmacological sciences _c11 2018 |
||
| 300 |
_a7938-7944 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetalloendopeptidases _xblood |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPatient Admission _xtrends |
| 650 | 0 | 4 |
_aPercutaneous Coronary Intervention _xadverse effects |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aST Elevation Myocardial Infarction _xblood |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLu, Q | |
| 700 | 1 | _aLiu, P | |
| 700 | 1 | _aBai, L | |
| 700 | 1 | _aQu, H | |
| 700 | 1 | _aMa, A-Q | |
| 773 | 0 |
_tEuropean review for medical and pharmacological sciences _gvol. 22 _gno. 22 _gp. 7938-7944 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.26355/eurrev_201811_16421 _zAvailable from publisher's website |
| 999 |
_c29149532 _d29149532 |
||